Thirty-nine weeks ended | | November 2, 2013 | | October 27, 2012 | |
| | | | | |
Cash flows from operating activities: | | | | | |
Net earnings | | $ | 10,196 | | $ | 27,351 | |
Adjustments to reconcile net earnings to net cash provided by continuing operations: | | | | | |
Net loss from discontinued operations | | 124 | | 122 | |
Depreciation | | 59,941 | | 59,279 | |
Amortization of deferred gain from asset sales | | (9,453 | ) | (9,453 | ) |
Amortization of deferred financing costs | | 1,952 | | 3,703 | |
Stock compensation expense | | 2,451 | | 622 | |
Deferred income taxes | | (478 | ) | 14,521 | |
Net loss from disposition of assets | | 213 | | 232 | |
Loss from asset impairment | | 4,882 | | 8,802 | |
Other | | (322 | ) | (62 | ) |
Changes in assets and liabilities: | | | | | |
Decrease in accounts receivable, prepaid expenses and other | | 18,431 | | 22,510 | |
Increase in merchandise inventories | | (23,693 | ) | (20,116 | ) |
Increase in accounts payable | | 7,746 | | 14,510 | |
Decrease in accrued expenses | | (6,589 | ) | (4,208 | ) |
Decrease in other long-term liabilities | | (2,354 | ) | (1,369 | ) |
Net cash provided by continuing operations | | 63,047 | | 116,444 | |
Net cash used in discontinued operations | | (193 | ) | (215 | ) |
Net cash provided by operating activities | | 62,854 | | 116,229 | |
| | | | | |
Cash flows from investing activities: | | | | | |
Capital expenditures | | (38,334 | ) | (36,760 | ) |
Proceeds from dispositions of assets | | 19 | | 15 | |
Acquisitions, net of cash acquired | | (10,741 | ) | — | |
Release of collateral investment | | 1,000 | | — | |
Net cash used in investing activities | | (48,056 | ) | (36,745 | ) |
| | | | | |
Cash flows from financing activities: | | | | | |
Borrowings under line of credit agreements | | 1,926 | | 1,780 | |
Payments under line of credit agreements | | (1,926 | ) | (1,780 | ) |
Borrowings on trade payable program liability | | 114,804 | | 123,408 | |
Payments on trade payable program liability | | (129,819 | ) | (82,904 | ) |
Payment for finance issuance cost | | — | | (6,442 | ) |
Borrowings under new debt | | — | | 200,000 | |
Debt payments | | (1,500 | ) | (295,122 | ) |
Proceeds from stock issuance | | 1,079 | | 1,999 | |
Repurchase of common stock | | (2,750 | ) | — | |
Net cash used in financing activities | | (18,186 | ) | (59,061 | ) |
Net (decrease) increase in cash and cash equivalents | | (3,388 | ) | 20,423 | |
Cash and cash equivalents at beginning of period | | 59,186 | | 58,244 | |
Cash and cash equivalents at end of period | | $ | 55,798 | | $ | 78,667 | |
| | | | | |
Supplemental cash flow information: | | | | | |
Cash paid for income taxes | | $ | 4,322 | | $ | 2,635 | |
Cash received from income tax refunds | | $ | 51 | | $ | — | |
Cash paid for interest | | $ | 9,149 | | $ | 28,554 | |
Accrued purchases of property and equipment | | $ | 2,369 | | $ | 2,008 | |